Research and Development

Sanofi and Alnylam have announced the expansion of their 2012 agreement to develop and sell treatments for rare genetic diseases. …

The effectiveness of healthcare communications is often more reliant on who’s delivering the message than the content of the message …

Medical devices firm Quanta Fluid Solutions has announced the appointment of John Milad as chief executive. Milad’s career spans 20 …

Amsterdam: CPhI, part of UBM Live, has announced the appointment of Chris Kilbee to the role of Group director of …

 British cancer deaths could drop 50% by 2030 if early diagnosis and improved treatment policies are put in place academics …

AC Immune, a privately-held biotech based in Switzerland, has launched the world’s first trial of a vaccine against a protein …

Merck Serono has appointed Steven Hildemann as global chief medical officer and head of its global Medical and Safety unit. …

The world’s biggest generic drugmaker Teva has appointed the chief executive of the world’s biggest generic agrochemical company. Vigodman joins …

PR firm Just:: Health Communications has hired Kirsty Mearns as a managing director to lead its senior management team.  She …

AstraZeneca’s biologics arm MedImmune has struck an oncology research deal with UK biotech company Immunocore. The deal, which could be …

UK Sterile manufacturing specialist SCM Pharma has appointed US-based business development manager Derek Richards. Richards will oversee the contract development …

 AstraZeneca has signed a deal with British biotech firm Horizon Discovery to look at a number of genotypes to see …

Six facilities in the US have received a total of $540 million from the estate of an American businessman in …

US biotech Capricor Therapeutics is being backed by Janssen Biotech to the tune of hundreds of millions of dollars to …

The Healthcare Corporation of America has appointed Natasha Giordano as its chief executive and Yaron Eitan as chairman of the …